To conclude, this study showed that EZH2 is an upstream regulator of miR-375 that increases miR-375 expression through STAT3 methylation and phosphorylation, while FOXO1 is a downstream target mRNA of miR-375 that activates the p53 signaling pathway to suppress BC development (Figure 8). The gene discussed is FOXO1; the disease is breast cancer.